Home Newsfeeds SVB Leerink Maintains Outperform on Biogen, Raises Price Target to $310

SVB Leerink Maintains Outperform on Biogen, Raises Price Target to $310

SVB Leerink analyst Marc Goodman maintains Biogen (NASDAQ:BIIB) with a Outperform and raises the price target from $270 to $310.

byBenzinga Newsdesk

October 26, 2022

1 minute read

SVB Leerink analyst Marc Goodman maintains Biogen (NASDAQ:BIIB) with a Outperform and raises the price target from $270 to $310.

DA Davidson Maintains Buy on Cars.com, Lowers Price Target to $17.5

By Benzinga Newsdesk

November 4, 5:14 AM

DA Davidson analyst Tom White maintains Cars.com (NYSE:CARS) with a Buy and lowers the price target from $18 to $17.5.

CARS

Village Farms International: Analyst Reduces Price Target But Maintains Overweight After Q4 Results

By Joana Scopel

March 10, 5:33 PM

Village Farms International Inc. (NASDAQ: VFF) recently reported its financial results for Q4 2022 in which revenue was $69.5 million, a decrease of 5% compared to $72.

CGC

Piper Sandler Maintains Overweight on Chord Energy, Lowers Price Target to $215

By Benzinga Newsdesk

July 22, 8:25 AM

Piper Sandler analyst Mark Lear maintains Chord Energy (NASDAQ:CHRD) with a Overweight and lowers the price target from $225 to $215.

CHRD

Movers
News

What’s Going On With CXApp Stock Wednesday?

By Adam Eckert

April 3, 8:55 AM

CXApp shares rallied more than 150% to start the week after the company announced a partnership with Alphabet Inc's Google Cloud. The stock pulled back significantly on Tuesday, closing the day down 27.1% at $4.48, but it's moving higher again on Wednesday.

CXAI

SVB Leerink Maintains Outperform on Biogen, Raises Price Target to $310

Related Posts

DA Davidson Maintains Buy on Cars.com, Lowers Price Target to $17.5

Village Farms International: Analyst Reduces Price Target But Maintains Overweight After Q4 Results

Piper Sandler Maintains Overweight on Chord Energy, Lowers Price Target to $215

What’s Going On With CXApp Stock Wednesday?